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Histone mRNAs are rapidly degraded at the end of S phase or when DNA replication is inhibited. Histone
mRNAs end in a conserved stem–loop rather than a poly(A) tail. Degradation of histone mRNAs requires the
stem–loop sequence, which binds the stem–loop-binding protein (SLBP), active translation of the histone
mRNA, and the location of the stem–loop close to the termination codon. We report that the initial step in
histone mRNA degradation is the addition of uridines to the 3 end of the histone mRNA, both after
inhibition of DNA replication and at the end of S phase. Lsm1 is required for histone mRNA degradation and
is present in a complex containing SLBP on the 3 end of histone mRNA after inhibition of DNA replication.
We cloned degradation intermediates that had been partially degraded from both the 5 and the 3 ends. RNAi
experiments demonstrate that both the exosome and 5-to-3 decay pathway components are required for
degradation, and individual histone mRNAs are then degraded simultaneously 5 to 3 and 3 to 5.
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Replication-dependent histone mRNA levels are tightly
coupled to DNA replication. Proper control of histone
protein synthesis is essential to ensure proper chromatin
formation. A major step in regulation of mammalian his-
tone mRNA is a rapid alteration in the half-life of his-
tone mRNA in response to changes in the rate of DNA
synthesis, allowing the cell to rapidly adjust the rate of
histone protein synthesis to maintain balanced synthesis
of DNA and histone protein. The regulation of the half-
life of histone mRNA is mediated by the unique 3 end of
histone mRNA (Pandey and Marzluff 1987; Kaygun and
Marzluff 2005b). The metazoan replication-dependent
histone mRNAs are the only eukaryotic mRNAs that are
not polyadenylated (Marzluff 2005). The stem–loop-
binding protein (SLBP) binds the conserved stem–loop
present at the 3 end of all five classes of histone mRNAs
(Wang et al. 1996; Martin et al. 1997). SLBP is required
for histone pre-mRNA processing (Marzluff 2005) and
accompanies the histone mRNA to the cytoplasm (Erk-
mann et al. 2005), where it is required for histone mRNA
translation (Sanchez and Marzluff 2002). SLBP plays a
direct role in histone mRNA stability through an inter-
action with Upf1 (Kaygun and Marzluff 2005a).
Inhibition of DNA replication using pharmacologic
agents results in a rapid degradation of histone mRNA.
Degradation requires active translation of the mRNA
and the stem–loop at the 3 end. The location of the
stem–loop relative to the stop codon, 45–80 nucleotides
(nt), is also essential, as increasing this distance results
in a loss of regulated degradation and persistent expres-
sion (Graves et al. 1987; Kaygun and Marzluff 2005b).
These characteristics suggest that a terminating ribo-
some must be in close approximation to the stem–loop
and likely SLBP. Supporting this model, we recently
found that Upf1, a factor involved in translation termi-
nation and nonsense-mediated decay (NMD), is required
for histone mRNA degradation (Kaygun and Marzluff
2005a).
The initial step in degradation of most polyadenylated
mRNAs in eukaryotes is shortening of the poly(A) tail by
a deadenylase complex (Parker and Song 2004). Dead-
enylated mRNAs can subsequently return to a transla-
tionally active state on polysomes, likely by the enzy-
matic action of cytoplasmic poly(A) polymerases (Coller
and Parker 2005) or can be degraded from either terminus
using a distinct set of nucleases. Upon poly(A) shorten-
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ing, the Lsm1–7 complex is thought to recruit a decap-
ping complex (Dcp1/Dcp2) to remove the 5 cap of the
mRNA (Coller et al. 2001). The decapped mRNA can
then be degraded 5–3 by the Xrn1 exoribonuclease or
can be exposed to a large complex of 3–5 exonucleases
known as the exosome (Mitchell et al. 1997). Several of
the proteins involved in catalyzing 5–3 degradation are
localized to discrete cytoplasmic loci termed P bodies or
GW bodies (Eystathioy et al. 2003; Sheth and Parker
2003). Whether 5–3 degradation is restricted to P bodies
is not known. Exosome components are located in both
the nucleus and the cytoplasm (Lejeune et al. 2003).
Whether both the 5–3 and 3–5 pathways can contrib-
ute to the degradation of a single mRNA molecule is not
clear.
The detailed biochemical pathway of regulated his-
tone mRNA degradation is not understood. Here we re-
port a novel pathway for histone mRNA degradation that
involves initial addition of uridines to the 3 end of his-
tone mRNA. Treatment of cells with hydroxyurea (HU)
results in a dramatic increase in oligouridylated histone
mRNAs, and at the end of S phase, cells also accumulate
oligouridylated histone mRNAs. The 3 oligo(U) tail
likely binds Lsm1–7, initiating degradation of the his-
tone mRNA. RNAi experiments also suggest a role for
both the exosome and the decapping enzymes in degra-
dation. In agreement with this result, we find interme-
diates of degradation that have been decapped and frag-
ments of histone RNAs that have been degraded from
both the 5 and 3 ends. In addition, we find intermedi-
ates where there has been initial partial degradation on
the 3 side of the stem–loop, and subsequent uridylation
of the partially degraded stem–loop, reminiscent of the
degradation of bacterial mRNAs (Kushner 2004). Two
candidate terminal uridylyl transferases (TUTases) have
been identified that are both required for histone mRNA
degradation. These two TUTases are localized to the cy-
toplasm, where they likely uridylate actively translating
histone mRNA substrates, modulating a dramatic de-
crease in their half-lives.
Results
Knockdown of 3hExo does not affect histone mRNA
degradation in vivo
Polyadenylated mRNAs are primarily degraded by a
pathway that initiates deadenylation, removing most of
the poly(A) tail, followed either by decapping and 5-to-3
degradation or degradation 3-to-5 by the exosome
(Parker and Song 2004). Although it is known that the
stem–loop at the 3 end of histone mRNA is the cis el-
ement that regulates histone mRNA degradation (Pan-
dey and Marzluff 1987), the biochemical details of his-
tone mRNA degradation are not known. Early studies by
Ross and coworkers (Ross and Kobs 1986; Ross et al.
1986, 1987) suggested that degradation of histone mRNA
proceeded 3 to 5. Since we recently identified an exo-
nuclease, 3hExo, that can specifically degrade histone
mRNA from the 3 end in vitro (Dominski et al. 2003),
and which can form a ternary complex with the stem–
loop of histone mRNA and SLBP, we tested whether the
3hExo might play a role in initiating histone mRNA
degradation. Since the critical cis element for histone
mRNA degradation is also at the 3 end of the mRNA,
we tested known factors in decay of polyadenylated mR-
NAs to see if they might also be involved in histone
mRNA degradation.
For all RNAi experiments, we knocked down the tar-
geted proteins using two sequential treatments with
siRNA (Wagner and Garcia-Blanco 2002) and used two
different siRNAs for each protein. Cells were treated
with a control siRNA (C2) that did not knock down any
of the proteins. We also used siRNAs that targeted the
splicing factor polypyrimidine tract-binding (PTB) pro-
tein, as a control. The cells were treated with 5 mM HU,
and the amount of histone mRNA degradation was mea-
sured over a 45-min time course.
The transfected siRNA reduced 3hExo protein levels
by 80%–90% as estimated by Western blot analysis of a
dilution series of control treated lysates (Fig. 1A). Total
RNA from these cells was subjected to Northern blot
analysis simultaneously probing for both histone H2a
mRNA and 7SK RNA as a loading control. Knockdown
of 3hExo has no effect on histone H2a mRNA degrada-
tion in HeLa cells (Fig. 1B,C). There was also no change
in the cell cycle distribution as determined by FACS
(Supplemental Fig. S1A). The steady-state levels of his-
tone mRNA in the exponentially growing cells (0 time
point) was similar in both the C2 (control) and 3hExo
knockdowns (Fig. 1B, cf. lanes 1 and 4). Thus, knock-
down of 3hExo had no discernable effect on histone
mRNA metabolism. Knocking down PTB also had no
effect on histone mRNA regulation or cell growth
(Supplemental Fig. S2A–C).
Lsm1 plays an integral role in replication-dependent
histone mRNA degradation
We tested several decay factors and enzymes involved in
regulating poly(A) mRNA stability by RNAi to see if any
of these factors affected histone mRNA degradation. The
Lsm1–7 complex is a heteroheptameric set of polypep-
tides that is a positive regulator of decapping in Saccha-
romyces cerevisiae (Tharun et al. 2000; Tharun and
Parker 2001) and has also been shown to be important in
regulating the stability of mRNAs containing AU-rich
elements (ARE) (Mukherjee et al. 2002; Stoecklin et al.
2006). We carried out a series of RNAi experiments as-
sessing the role of various factors using C2 siRNA as a
negative control and Upf1 as a positive control for a fac-
tor that reduces histone mRNA degradation. Each ex-
periment shown represents an example of a panel of ex-
periments done on parallel cultures.
The down-regulation of Lsm1 protein varied from 75%
to 95% among different experiments as estimated from
the protein dilution series of the control (C2) sample (Fig.
1D). Each siRNA had a similar degree of knockdown, and
Symplekin, a scaffold protein involved in mRNA 3 end
formation (Takagaki and Manley 2000; Kolev and Steitz
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2005), served as a loading control in this experiment. We
showed previously that the NMD factor hUpf1 is impor-
tant in regulating the rapid decay of histone mRNA (Kay-
gun and Marzluff 2005a), and we used this as a positive
control. Transfection of either of two siRNAs targeting
Lsm1 resulted in stabilization of histone mRNA at the
20-min time point (Fig. 1E, cf. lanes 2, 5, and 8) and over
a 2.5-fold stabilization at the 45-min time point (Figs. 1E
[cf. lanes 3, 6, and 9], 3G [below]) relative to C2 siRNA-
transfected cells. Figure 1F summarizes three indepen-
dent RNAi experiments. The cell cycle distributions of
the cells were not significantly changed by the Lsm1
knockdown (Supplemental Fig. S1B).
Given the apparent role of Lsm1 in histone mRNA
Figure 1. Effect of knockdown of 3hExo or Lsm1 on histone mRNA degradation. HeLa cells were treated with the 3hExo (A–C) or
Lsm1 (D–F) siRNAs as described in Materials and Methods, and then treated with 5 mM HU and total cell RNA prepared 0, 20, or 45
min after HU treatment. (A,D) A dilution series of the control (C2) cell lysate together with a lysate from cells treated with the
indicated siRNA was analyzed by Western blotting for 3hExo and Upf1. The asterisk indicates a cross-reacting band. (B,E) Two
micrograms of total cell RNA were resolved by urea acrylamide gel electrophoresis, transferred to N+ nitrocellulose, and probed with
a mixture of histone H2a mRNA and 7SK snRNA probes. (C,F) The average of three independent experiments is shown. (C) () C2;
() 3hExo. (F) () C2; () Lsm1-1; () Lsm1-2; () Upf1. Standard deviations are indicated by vertical bars. (G) Lysates were prepared
from S-phase cells expressing HA-SLBP 15 min after treatment with HU as described previously (Kaygun and Marzluff 2005a). (Top,
lane 3) A portion of the lysate was treated with RNase A (20 µg/mL) for 15 min prior to immunoprecipitation with anti-HA antibody.
The immunoprecipitates were analyzed for SLBP and Lsm1 by Western blotting. (Bottom) S-phase cells expressing HA-SLBP were
treated with HU for 15 min; lysates were prepared and subjected to immunoprecipitation with anti-myc (lanes 3,4) or anti-HA (lanes
5,6) antibodies. The immunoprecipitates were analyzed for SLBP, Lsm1, and PTB as a control by Western blotting. (Lanes 1,2) The
input lanes show 5% of the total lysate.
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decay, we asked whether we could detect Lsm1 in SLBP
immunoprecipitates when histone mRNAs were being
rapidly degraded. Lysates were prepared 15 min after HU
treatment from S-phase cells stably expressing HA-
tagged SLBP (Erkmann et al. 2005) and immunoprecipi-
tated with anti-HA antibody. We then probed for Lsm1.
Detectable amounts of Lsm1 were coimmunoprecipi-
tated with HA-SLBP. When we treated the cell lysates
with RNase A prior to immunoprecipitation, the
amount of Lsm1 coimmunoprecipitated was greatly re-
duced (Fig. 1G, top, lanes 3,4). This result suggests that
both SLBP and Lsm1 can be bound to histone mRNA but
that they do not stably interact with each other, in con-
trast to the interaction of SLBP and Upf1, which is resis-
tant to RNase digestion (Kaygun and Marzluff 2006). In a
separate experiment, we did not detect association of
Lsm1 with SLBP in S-phase cells prior to HU treatment,
although it was readily detected 15 min after HU treat-
ment (Fig. 1G, bottom, lanes 5,6). Another RNA-binding
protein, PTB, was not present in any of the SLBP immu-
noprecipitates, demonstrating the specificity of the in-
teraction. Thus Lsm1 only interacts with SLBP when
histone mRNA is being rapidly degraded.
Down-regulation of the decapping enzyme Dcp2
and the 5–3 exonuclease Xrn1 reduces histone
mRNA decay
Since the Lsm1–7 complex is a positive regulator of de-
capping and 5–3 decay and had an effect on histone
mRNA stability, we examined other components of the
5–3 mRNA decay apparatus. We knocked down the
catalytic subunit of the decapping complex Dcp2 (Wang
et al. 2002) and the 5–3 exonuclease Xrn1/Rat1 (Long
and McNally 2003) using targeted siRNAs to these en-
zymes. Each protein was knocked down by an estimated
80%–90% (Fig. 2A,D). As an alternative method to
Northern blots, we used an S1 nuclease protection assay
to monitor histone H2a mRNA levels (Kaygun and Mar-
zluff 2005a,b). HU treatment does not affect polyadenyl-
ated H3.3 mRNA levels and thus serves as a loading
control. The degradation of histone mRNA was reduced
by knocking down Dcp2 and Xrn1, and after 45 min of
HU treatment, there was twice as much histone mRNA
remaining compared with control treated cells (Figs.
2B,C,E,F, 3G).
The down-regulation of both Dcp2 and Xrn1 had mini-
mal effects on the cell cycle distribution of the cells
(Supplemental Fig. S1C,D). There was a small increase in
the percentage of S-phase cells of the Dcp2 knockdown
compared with the control (Supplemental Fig. S1C). This
likely accounts for the small increase in steady-state his-
tone H2a mRNA levels (Fig. 2B, cf. lanes 1 and 3) in the
Dcp2 knockdown cells. These data lead us to conclude
that components of the 5-to-3 degradation pathway
also play a role in histone mRNA degradation.
Knocking down exosome components PM/Scl-100
and Rrp41 inhibits histone mRNA degradation
Polyadenylated mRNAs may also be degraded by the
exosome following deadenylation, in addition to degra-
Figure 2. Effect of decapping complex and 5–3
exonuclease knockdown on histone mRNA degrada-
tion. HeLa cells were treated with the indicated siR-
NAs to Dcp2 (A–C) or Xrn1 (D–F) and treated with 5
mM HU as described in Figure 1. (A,D) Protein lev-
els of knockdowns were measured by Western blot
using antibodies to Dcp2 (A) and Xrn1 (D). (B,E) S1
nuclease protection assays of 5 µg of total RNA iso-
lated from cells treated with 5 mM Hu for 0, 20, or
45 min from Dcp2 (B) or Xrn1 (E) knockdowns. Hu-
man H3.3 and H2a mRNAs were detected by mixing
probes to detect the 3 and 5 ends of H3.3 and H2a
mRNAs, respectively. (C,F) The average of three in-
dependent experiments from Dcp2 (C) and Xrn1 (F)
knockdowns is shown. The vertical bars indicate the
standard deviation.
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dation 5 to 3 through the decapping pathway. It is pos-
sible that the Lsm1–7 complex could also recruit the
exosome. To determine whether the exosome may also
play a role in histone mRNA degradation, we knocked
down two components of the exosome by RNAi. We
chose PM/Scl-100 and Rrp41, a core exosome compo-
nent (Liu et al. 2006). PM/Scl-100 has been shown to be
present in the cytoplasm of human cells (Lejeune et al.
2003), in contrast to initial reports (Allmang et al. 1999).
PM/Scl-100 has substantial homology with Escherichia
coli RNase D, a 3–5 exonuclease, and Rrp41 has been
shown to have 3–5 exonuclease activity in vitro
(Mitchell et al. 1997).
The RNAi treatment reduced PM/Scl-100 levels by
∼80% (Fig. 3A), and two different siRNAs against Rrp41
reduced its levels by at least 80% (Fig. 3D). Knocking
down either PM/Scl100 (Fig. 3B) or Rrp41 (Fig. 3E) had a
significant effect on histone mRNA degradation, similar
to that seen with knocking down Lsm1. The average of
three independent experiments is shown in Figure 3, C
and F. There was a threefold stabilization of histone
mRNA 45 min after HU treatment when PM/Scl-100 is
knocked down and a 2.3-fold stabilization when Rrp41
was knocked down (Fig. 3G). Knocking down the exo-
some components had no effect on cell growth or cell
cycle distribution (Supplemental Fig. S1E,F).
Determination of the 5 and 3 ends of individual
histone mRNA molecules in vivo
To directly identify molecules that had been partially
degraded, we used a circularization RT–PCR (cRT–PCR)
strategy in which the 5 (containing a 5 phosphate) and
3 ends (with a 3 OH) are ligated to each other, forming
a circular RNA. One can then amplify the region con-
taining the ligated 5 and 3 ends by RT–PCR. This
method allows one to determine the 5 end and the 3
end of individual molecules. The ends of molecules that
have 5 caps can be detected by first treating the RNA
with tobacco acid pyrophosphatase (TAP). This method
has been used to directly analyze deadenylated mRNAs
in cells (Fromont-Racine et al. 1993; Couttet et al. 1997).
A schematic of this RT–PCR strategy, adapted from
Couttet et al. (1997), is depicted in Figure 4A. We de-
signed primers to target histone H3 mRNA from two
identical genes (HIST2H3A and HIST2H3C) of the 12
Figure 3. Effect of knockdown of exosome com-
ponents on histone mRNA degradation. (A,D)
HeLa cells were treated with the indicated
siRNAs to PM/Scl-100 (A–C) or Rrp41 (D–F) and
were treated with 5 mM HU, and the levels of
each protein were determined by Western blot-
ting as in Figures 1 and 2. (B,E) Two micrograms
of total cell RNA from cells with PM/Scl100
knocked down (B) or Rrp41 knocked down with
two siRNAs (5 and 6) to Rrp41 were resolved by
urea-acrylamide gel electrophoresis and probed
with a mixture of histone H2a mRNA and 7SK
snRNA probes as in Figure 1. (C,F) The average of
three independent knockdowns to PM/Scl-100
(C: , C2; , PM/Scl-100) and Rrp41 [F: , C2;
, Rrp41(1); --, Rrp41(2)] is shown. (G) Average
fold stabilization of all experiments shown in
Figures 1–3, with standard deviations indicated
by vertical bars.
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annotated histone H3 genes in the human genome (Mar-
zluff et al. 2002).
As a control to demonstrate that we could identify the
authentic 3 ends of histone mRNAs, we analyzed the 3
end of histone H2a mRNA formed in an in vitro process-
ing reaction. After processing, we recovered only histone
RNA that ended with the conserved ACCCA nucleo-
tides following the base of the stem–loop, precisely
where we and others (Scharl and Steitz 1994; Dominski
et al. 2005) mapped the cleavage site in vitro (Supple-
mental Fig. S3A). These results demonstrate that we
were able to recover RNA molecules that had their 3
and 5 ends intact, and hence nuclease activity in our
reagents was minimal.
Figure 4B shows the results from a cRT–PCR experi-
ment using RNAs from control cells and cells treated
with HU for 20 min, at which time ∼40% of the histone
mRNA has been degraded. Two amplicons were detected
(∼190 and 235 nt) when TAP was used to decap the
mRNA (Fig. 4B, lanes 3,4), and these were more abun-
dant in RNA from untreated cells compared with HU-
treated cells. No amplified products were detected by
Figure 4. Detection of the 5 and 3 ends of capped histone H3 mRNA in vivo and determination of the sequence of decapped histone
H3 mRNA degradation intermediates. (A) The cRT–PCR strategy to determine the ends of intact histone mRNA and degradation
intermediates is shown (adapted from Couttet et al. 1997; © 1997 National Academy of Sciences, USA). (B) cRT–PCR reactions with
and without decapping from total cell RNA were separated on 1.5% agarose gels, and amplicons were detected by ethidium bromide
staining. Two human histone H3 mRNAs are visualized in the +TAP lanes. (C) The 3 end of a synthetic histone pre-mRNA substrate
processed in vitro and decapped differs from histone mRNA decapped and retrieved from the cell. In vitro processed pre-mRNA and
total cell RNA were decapped (+TAP), subjected to cRT–PCR, and cloned. Complete sequences of these experiments are presented in
Supplemental Figure S4. (D,E) cRT–PCR was performed on total cell RNA, and the histone H3 products were amplified, cloned, and
sequenced. HIST2H3A/C (D) or HIST2H3D (E) mRNAs that were not capped were cloned by cRT–PCR. Primers 2 and 3 represent sites
where we targeted amplification toward the 5 and 3 ends. ORF sequences between these two oligonucleotides are missing. Numbers
in parentheses are the number of times each clone was obtained. (F,G) The 3 ends from the largest HIST2H3A/C (F) and HIST2H3D
(G) mRNA degradation intermediates are shown. The number of times each sequence was obtained is indicated by a number in
parentheses. (H) Chromatogram from a HIST2H3D mRNA degradation intermediate containing eight untemplated Us (Ts in the DNA
sequence). The 3 and 5 ends were ligated (arrow) together.
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ethidium bromide staining when the RNA was not
treated with TAP (Fig. 4B, lanes 1,2).
We cloned these two PCR products and sequenced
multiple clones from each fragment. The 235-nt frag-
ment was derived from the HIST2H3A, HIST2H3C
genes we initially set out to amplify (Marzluff et al.
2002), while the 187-nt band was a previously unanno-
tated histone H3 gene also found in the minor histone
cluster on chromosome 1q21 (nucleotides 276,048–
275,157), which we named HIST2H3D (see below). Each
of these genes is highly expressed in HeLa cells. Supple-
mental Figure S3, B and C, shows sequences for the 5
and 3 regions of these two genes. The top line
(HIST2H3A/C or HIST2H3D) gives the genomic se-
quence of these genes, extending from the region up-
stream of the TATA box into the ORF, and from the stop
codon past the HDE. The 5 untranslated region (UTR) of
the HIST2H3A/C mRNAs is 47 nt, with the G at the
start site located 27 nt from the TATAA box, the ex-
pected distance for an RNA polymerase II transcription
initiation site. This G was ligated to an ACC sequence
that follows the stem–loop in 10 of the 11 circularized
clones isolated. The cytoplasmic histone mRNA is thus
2 nt shorter than the mRNA formed by the in vitro pro-
cessing reaction. In one clone the last 2 nt of the stem
were missing, and these were followed by several non-
templated Us (Fig. 4C; Supplemental Fig. S4B, clone 2).
As shown below, we believe that this clone likely repre-
sents a degradation intermediate. This clone had two
additional nucleotides, a GT that could be part of the
nontemplated 3 UTR or result from slippage in the oli-
go(T) stretch in the 5 UTR.
Similar results were observed with the clones from the
187-nt fragment. These clones were also essentially
identical and correspond to the HIST2H3D gene. The 5
UTR of this mRNA is extremely short, only 11 nt from
the A in the ATG codon in 23 of the 28 clones, which is
located 27 nt from the TATAA box. The small amount of
heterogeneity at the 5 end of the mRNA (one clone,
Supplemental Fig. S3C, clone 2) starting at the C, 1 nt
upstream, and another (Supplemental Fig. S3C, clone 1)
at an A 3 nt upstream of the major start site, likely rep-
resents the use of closely spaced transcription start sites,
all of which were ∼25 nt from the TATAA box. The 3
end of the mRNA in 23 of the 28 clones (Supplemental
Fig. S3C, clones 2 and 3) is 3 nt after the stem–loop; one
ends 2 nt after the stem–loop (Supplemental Fig. S3C,
clone 4), and the other four clones (Supplemental Fig.
S3C, clone 1) may have a single nontemplated U (or the
U may represent an alternative start site and may be the
first nucleotide of the transcript). Note that this gene has
an unusual sequence after the stem–loop ACTGC rather
than the consensus ACCCA.
These results confirmed our ability to obtain full
length 5 and 3 UTRs using the cRT–PCR procedure
from total cellular RNA. Although the histone mRNA
formed by cleavage of the histone pre-mRNA ends 5 nt
after the stem–loop, the cytoplasmic histone mRNAs
end only 2–3 nt after the stem–loop. Thus there must be
trimming of 2 nt from the processed mRNA at some
point after the processing reaction, and this may be a
function of the 3hExo, which has this activity in vitro in
the presence of SLBP (Dominski et al. 2003; Yang et al.
2006).
cRT–PCR products of uncapped histone H3 mRNA
identifies degradation intermediates containing
oligouridine on the 3 end of the mRNA
If decapping occurs during histone mRNA degradation,
then we could potentially circularize decay intermedi-
ates of histone mRNAs, allowing us to clone single mol-
ecules of partially degraded histone mRNA. Because our
primers are located near the end of each ORF, we will
preferentially isolate intermediates from early in the
degradation process. We cloned all the products of the
circular RT–PCR reactions starting with the RNAs not
treated with TAP, although we could not see any ampli-
fied products in these reactions. Unlike the clones ob-
tained by TAP treatment, these clones were heterog-
eneous in size, accounting for the failure to see discrete
bands. We sequenced these clones, and all of them rep-
resented fragments from either the HIST2H3A/C genes
(Fig. 4D) or HIST2H3D gene (Fig. 4E).
Only four of the 37 clones we obtained were from full-
length mRNAs (Fig. 4D [clone 2], E [clone 5]). The re-
maining 33 clones encoded 28 shorter mRNAs—with
nucleotides removed from either the 5 end (Fig. 4D;
Supplemental Fig. S5A, clone 5), the 3 end (11 clones)
(Figs. 4D [clones 3, 4, and 7–9], 5E [clones 6, 9, and 10]) or
both (16 clones) (Fig. 5D [clones 6 and 11–20], E [clones 7,
8, and 10–12])—and five encoded mRNAs that had non-
templated Us added to the 3 end (Fig. 5D [clone 1 from
HIST2H3A/C], E [clones 1–4 from HIST2H3D]).
Most striking were the five mRNAs that contained
eight to 10 nontemplated uridines added to the 3 end of
the mRNA, starting 3 nt after the stem–loop, the site
where we mapped the 3 end of the cytoplasmic mRNA
(Supplemental Fig. S3B,C). Two of these clones con-
tained a single A (Fig. 4E, clone 1) or C (Fig. 5B, clone 3)
in the oligo(U) tract. One of these mRNAs from the
HIST2H3D mRNA had lost 8 nt from the 5 end. The
mRNA from the HIST2H3A/C genes (Fig. 4D, clone 1)
contains at least eight nontemplated Us at the 3 end.
Since there is also a string of five Us in the 5 end just
after the cap, it is also possible that this clone comes
from a decapped mRNA that has lost a few nucleotides
from the 5 end. Figure 4, F and G, summarizes the 3
ends of the HIST2H3A/C (Fig. 4F) and the HIST2H3D
(Fig. 4G), showing the nontemplated Us as well as partial
degradation of the 3 side of the stem. An example of the
sequence of a clone containing non-templated Us is
shown in Figure 4H.
Histone H2a and H3 mRNAs acquire oligo(U) tails
after addition of HU
In order to detect mRNAs containing oligouridylated
tails added to the 3 end of histone mRNA, we developed
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a nested RT–PCR strategy, depicted in Figure 5A. First
we primed reverse transcription with an oligonucleotide
containing a T7 promoter sequence followed by eight As
to make cDNAs from all RNAs containing an oligo(U)
sequence. A specific primer targeting the 5 UTR of a
histone gene and the T7 primer were used for the first
round of PCR. The nested PCR reaction used a histone
ORF primer with the same reverse T7 promoter primer.
We targeted the same two H3 genes used in the cRT–
PCR studies and in addition targeted an H2a mRNA
(HIST2H2AA). We prepared total RNA at 0, 15, 30, and
60 min after initiating histone mRNA degradation by
treating cells with HU to inhibit DNA synthesis. As a
control, we used an oligo(dT) oligo followed by the T7
sequence (Supplemental Fig. S4B,C).
At 0 time, there is no amplicon of oligouridylated his-
tone mRNA detected from either the HIST2H2AA
mRNA or the HIST2H3A/C and HIST2H3D mRNAs
(Fig. 5B, lane 2). After 15 min, a robust band is detected,
which subsequently declines in intensity at 30 min and
is almost entirely gone at 60 min, coinciding with the
near completion of histone mRNA degradation (Fig. 5B,
lanes 3–5). We cloned the amplicons from the 0- and
15-min time points. There was a striking difference in
colony number on the transformed H2a plates, with only
a few colonies present on the 0 min plates compared
with hundreds of colonies present on the 15-min plates
(Supplemental Fig. S4A), consistent with the increased
amount of RT–PCR product after HU treatment. We se-
quenced amplicons cloned after HU treatment, and these
all were derived from histone mRNAs containing oli-
go(U) tails at or near the 3 end of these histone mRNAs.
They contained eight Us (the number of Us in the
primer) that were added either to the very terminal end
(3 nt after the stem–loop) of the mRNA or somewhere
within the stem–loop (Fig. 5C). The latter observation
suggests that multiple rounds of oligo(U) addition may
occur near the 3 end of the mRNA, possibly because
degradation may stall in the stem–loop, and the degra-
dation must be primed again.
In the HIST2H2A/C (Fig. 5B, middle panel, lane 2) and
the HIST2H3D (Fig. 5B, bottom panel, lanes 2,5) reac-
tions, we detected a nonspecific band at the 0 time point
that is absent after HU treatment for 15 or 30 min, but is
Figure 5. Detection of oligouridylated histone
mRNAs after inhibition of DNA synthesis and at
the end of S phase. (A) RT–PCR strategy to detect
oligo(U)-containing histone mRNA molecules.
Total RNA from HeLa cells was primed for
cDNA synthesis using an oligo(dA) primer fused
to a T7 sequence. Two rounds of PCR (30 cycles
each) were performed using oligos targeting the
5 UTR (first round) or the ORF (second round)
and a primer complementary to the T7 sequence.
(B) Oligo(dA) RT–PCR from HIST2H2AA,
HIST2H3A/C, and HIST2H3D treated with HU
for 0, 15, 30, and 60 min. The products were re-
solved by agarose gel electrophoresis and were
detected by ethidium bromide staining. Asterisk
indicates a nonspecific band. (C) Sequences from
oligo(dA) RT–PCR reactions from the HIST2H3D
mRNA when treated with HU for 15 min. The
number in parentheses indicates the number of
times a particular sequence was observed. (D)
HeLa cells were synchronized by DTB and re-
leased into S phase, and protein samples were
collected at the indicated times. Western blot
analysis of SLBP and cyclin A was performed. (E)
Total RNA was isolated from the same cells as in
D, and H2a mRNA and 7SK RNA levels were
measured by Northern blotting. (F) Oligo(dA)
RT–PCR on total RNA from the middle and end
of S phase into the G2 phase of the cell cycle.
Total RNA from the indicated time points
following release from DTB was subjected to
the RT–PCR strategy depicted in A to detect
HIST2H2AA and HIST2H3D mRNA and was re-
solved on a 2.0% agarose gel. HU was added at 3
h for 15 min in lane 3. (G) The oligo(dA) primed
RT–PCR products from the 5.5- and 6.0-h time
points were cloned, and several clones from the
HIST2H2AA and HIST2H3D mRNAs were
cloned and sequenced.
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present at 60 min when most of the histone mRNA has
been degraded. We sequenced clones from the 0 time
point of the H3 oligo(dA) RT–PCRs, and the nonspecific
band was a primer dimer sequence containing the two
histone primers and a small sequence of H3 ORF fol-
lowed by the reverse T7 promoter primer (primer dimer
of three oligos).
Addition of adenosines to the 3 end of many RNAs is
a prerequisite to degradation of RNAs by the exosome in
the nucleus (LaCava et al. 2005; Vanacova et al. 2005).
To test whether polyadenylation might also play a role
in histone mRNA degradation, we attempted to detect
poly- or oligoadenylated histone mRNAs after inhibiting
DNA replication by a similar strategy used to amplify
the oligouridylated histone mRNAs. As a positive con-
trol for the oligo(dT) oligo, we used SLBP knockdown
cells that have been shown to result in accumulation of
some polyadenylated histone mRNA as a result of mis-
processing (Narita et al. 2007). We readily detected poly-
adenylated histone mRNAs in the SLBP knockdown
cells, but did not detect any oligoadenylated histone
mRNAs in control cells or cells treated with HU (Supple-
mental Fig. S4B,C). In addition, our unbiased sequencing
of circularized histone mRNAs never yielded oligo-
adenylated mRNAs.
Oligouridylated histone mRNAs are present at the end
of S phase but not in mid S phase
Histone mRNAs are rapidly degraded at the end of S
phase. To determine if the oligouridylation is present
normally at the end of S phase, we synchronized HeLa
cells by double thymidine block (DTB) (Whitfield et al.
2000). As a positive control, we treated mid-S-phase cells
(3 h after release from the thymidine block) for 15 min
with HU. We prepared whole-cell lysates for Western
analysis and total RNA for Northern blot analysis and
oligo(dA) RT–PCR at various times beginning from the
middle of S phase but focusing particular attention to the
end of S phase. Figure 5D (top panel) is a Western blot
showing that SLBP protein levels are high in S phase and
decrease rapidly upon completion of DNA synthesis and
increase in abundance again when cells approach the
subsequent S phase (Whitfield et al. 2000). We also de-
termined cyclin A levels, a mitotic cyclin that is de-
graded at anaphase as cells exit mitosis. Northern blot
analysis was performed for hH2a mRNA using 7SK
snRNA as a loading control (Fig. 5E). Histone H2a
mRNA is rapidly degraded upon the completion of S
phase, then reaccumulates upon entry into the subse-
quent S phase. Figure 5F shows the results from oligo(dA)
RT–PCR at various times in S phase and upon the
completion of DNA sythesis. At 0 and 3 h following
release from DTB, there was little to no detection of
oligouridylated HIST2H2AA or HIST2H3D mRNA (Fig.
5F, lanes 1,2). When HU was added for 15 min at 3 h,
oligouridylated HIST2H2AA and HIST2H3D mRNA ac-
cumulated (Fig. 5F, lane 3). Starting 5 h after release into
S phase, we detected oligouridylated histone mRNA (Fig.
5F, lane 4), and the amount increased at 5.5–6 h for both
HIST2H2AA mRNA (Fig. 5F, lane 5) and HIST2H3D
mRNA (Fig. 5F, lane 6). The levels of oligouridylated
histone mRNAs declined at 6.5 h and were no longer
detectable 7 h during G2 phase. We sequenced oligo-
uridylated RT–PCR products for both HIST2H2AA and
HIST2H3D from the 5.5- and 6-h time points. Consistent
with the results after HU treatment (Fig. 5D), we found
oligouridylated tails present at the end of S phase on both
the 3 end of the histone mRNA as well as within the
stem–loop sequence. Note that the oligo(U) tails were
often interrupted by another nucleotide, which is char-
acteristic of other terminal transferases (Kwak and Wick-
ens 2007).
Two putative cytoplasmic TUTases are required
for efficient histone mRNA degradation
The addition of nontemplated uridines to the 3 end of
histone mRNA requires a 3-terminal transferase activ-
ity. We searched the human genome for putative
TUTase enzymes that contain the PAPD/TRF domain, a
domain found in the human CID1 (Rissland et al. 2007)
and U6 snRNA TUTase (Trippe et al. 2006). We identi-
fied seven putative TUTases (one of them being the U6
TUTase) and designed siRNAs targeting each one and
knocked them down in HeLa cells. To demonstrate the
efficiency of the siRNAs at the protein level, we coex-
pressed myc-tagged TUTases and found that the siRNAs
efficiently depleted the exogenously expressed TUTases
(Fig. 6A) by Western blotting. In addition, we determined
whether the siRNAs reduced the endogenous TUTase
mRNA levels by RT–PCR. We assessed the knockdown
at the RNA level using 7SK snRNA as a loading control
(Fig. 6B; Supplemental Fig. S6). Knocking down the U6
TUTase was lethal as previously reported (Trippe et al.
2006). Of the remaining six TUTases, knocking down
two (TUTase-1 and TUTase-3) reduced the rate of his-
tone mRNA degradation after HU treatment (Fig. 6C
[lanes 4–9], D). Knocking down the other four enzymes,
TUTase-2, TUTase-4, TUTase-5, and TUTase-7 (Fig. 6C
[lanes 10–12], D), had no effect on histone mRNA degra-
dation.
Since histone mRNAs are degraded in the cytoplasm,
we determined the subcellular localization of the
TUTase-1 and TUTase-3 by transiently transfecting
HeLa cells with various doses of myc-tagged plasmids
encoding these proteins, followed by confocal immuno-
fluorescence. TUTase-1 is exclusively cytoplasmic,
while TUTase-3 is predominantly cytoplasmic but is
also present in the nucleus in some cells (Fig. 6E). The
localization is consistent with a role for these enzymes
in histone mRNA degradation.
Note that the TRAMP complex that adds adenosines
to nuclear RNAs to prime their degradation are in this
same family of enzymes (Vanacova et al. 2005; Rissland
et al. 2007). We could not determine which of the human
family members correspond to the Trf4/5 enzyme. How-
ever, since that enzyme is strictly nuclear, it is very un-
likely that TUTase-1 or TUTase-3 is responsible for this
activity.
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Discussion
mRNA degradation is an important step in regulating
gene expression, and destabilizing an mRNA is the only
way to rapidly reduce mRNA levels when necessary. The
pathway of mRNA degradation for most polyadenylated
mRNAs has been determined over the past decade (for a
recent review, see Garneau et al. 2007). The initial step is
the shortening of the poly(A) tail. Once the poly(A) tail is
short enough that it can no longer bind PABP, Lsm1–7
can bind the 3 end and likely recruits Pat1, effectively
inhibiting translation. The Lsm1–7 complex also stimu-
lates decapping, allowing rapid degradation 5 to 3 by
Xrn1, the cytoplasmic 5-to-3 exonuclease. Following
deadenylation, the mRNA may also be degraded 3 to 5
by the exosome. In yeast, the 5-to-3 and the 3-to-5
degradation pathways are redundant, although the major
pathway of mRNA degradation is 5 to 3 using the de-
capping machinery. Yeast mutants for members of either
pathway are viable, but debilitation of both pathways
results in lethality. Thus it is likely the two pathways
are redundant and that most mRNAs in yeast can be
degraded by either pathway (Caponigro and Parker 1996).
A third pathway of mRNA degradation is endonucleo-
lytic cleavage, followed by 5-to-3 degradation of the 3
fragment, and degradation of the 5 fragment either by
the exosome or by decapping followed by the 5-to-3
exonuclease. This pathway is used for degradation of
mRNAs by siRNAs (Orban and Izaurralde 2005) and
some endonucleases involved in degradation of specific
mRNAs (Yang and Schoenberg 2004) or in NMD in Dro-
sophila (Gatfield and Izaurralde 2004).
Histone mRNAs are the only mRNAs that are not
polyadenylated, ending instead in a conserved stem–loop
sequence. A major step in regulating histone mRNA lev-
els is rapid degradation of histone mRNA, mediated by
the stem–loop as the cis element that directs the degra-
dation of histone mRNA. Despite the fact that the cis
element that determines histone mRNA degradation has
been known for 20 years (Pandey and Marzluff 1987), the
details of the biochemical pathway for degradation of
histone mRNA are not known.
Figure 6. RNAi screen to seven TUTases
present in the human genome identifies two
putative TUTase involved in histone mRNA
degradation. The seven TUTases were
knocked down using specific siRNAs as in
Figure 1. (A) A representative experiment to
determine the efficacy of TUTase siRNAs.
Myc epitope-tagged TUTases were cloned and
transfected at the time of the second hit of
siRNA (see Materials and Methods). Protein
lysates were harvested 48 h following the sec-
ond hit and probed by Western using an anti-
myc antibody. Upf1 was used as a loading
control. (B) Endogenous TUTase mRNA lev-
els were measured by RT–PCR. Two micro-
grams of total RNA were random primed and
subjected to MMLV reverse transcriptase fol-
lowed by PCR. The degree of knockdown,
relative to 7SK RNA as a control, estimated
by RT–PCR is indicated. (C) Knockdown of
TUTase-1 and TUTase-3 stabilizes histone
H2a degradation following inhibition of DNA
synthesis by HU. Two micrograms of total
cell RNA from cells treated with 5 mM HU
were resolved by urea acrylamide gel electro-
phoresis and analyzed with a mixture of his-
tone H2a mRNA and 7SK snRNA probes. (D)
The rate of degradation of histone mRNA in
three independent experiments where the dif-
ferent TUTases were knocked down. Lsm1
was included as a positive control. Standard
deviations are represented by vertical bars.
The U6 TUTase is essential for cell viability,
and the effect on histone mRNA degradation
could not be determined (see text for details).
(E) TUTase-1 and TUTase-3 are localized pre-
dominantly in the cytoplasm of HeLa cells.
Cells were transfected with myc-tagged
clones of TUTase-1 or TUTase-3, and the
tagged proteins were detected by immuno-
fluorescence 48 h following transfection.
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In this study, we demonstrate three features of histone
mRNA degradation: (1) There is oligouridylation of the
3 end of histone mRNA when DNA replication is in-
hibited and at the end of S phase, and this is likely the
step that initiates histone mRNA degradation. (2) Lsm1
is essential for histone mRNA degradation, suggesting
that Lsm1–7 binds to the oligo(U) tail that is added to
histone mRNA. (3) Both the 5 pathway and the 3 path-
way are involved in histone mRNA degradation, and in-
dividual molecules of histone mRNA can be simulta-
neously degraded 5 to 3 and 3 to 5.
Both the 5 and 3 degradation pathways contribute
to histone mRNA degradation
Previous work by Ross and coworkers (Ross and Kobs
1986; Ross et al. 1986, 1987) had implicated 3-to-5 deg-
radation as the major pathway of histone mRNA degra-
dation, largely based on in vitro studies. Despite the fact
that the 3hExo can potentially degrade the 3 end of
histone mRNA, we find no evidence for a role of this
enzyme in histone mRNA degradation in mammalian
cells (Fig. 1) or Drosophila (Kupsco et al. 2006). In con-
trast, knocking down components of both the 5-to-3
decay pathway or the exosome resulted in a reduced rate
of degradation of histone mRNA when DNA replication
was inhibited (Figs. 2, 3). Strikingly, knocking down
Lsm1 had a large impact on histone mRNA degradation.
The cytoplasmic complex Lsm1–7 is essential for degra-
dation of polyadenylated mRNAs and binds to short
ssRNAs at the 3 end of deadenylated mRNAs (Tharun
and Parker 2001). It functions both to block translation
by recruitment of Pat1 (Coller and Parker 2005), as well
as to initiate degradation of the body on the mRNA by
recruitment of the decapping complex (Tharun and
Parker 2001; Tharun et al. 2005), and possibly also the
exosome (Lehner and Sanderson 2004). Given that his-
tone mRNAs lack an obvious binding site for Lsm1–7,
the finding that Lsm1 was critical for histone mRNA
degradation was surprising.
Model of histone mRNA degradation
Histone mRNA degradation in the cytoplasm is triggered
by inhibition of DNA replication in the nucleus. Previ-
ous work together with these results allow us to propose
a model for histone mRNA degradation (Fig. 7). The
stem–loop is the cis element responsible for histone
mRNA degradation. It must be located an appropriate
distance from the termination codon and requires ongo-
ing translation (Graves et al. 1987; Kaygun and Marzluff
2005b). We postulated that inefficient translation termi-
nation is the critical event for triggering histone mRNA
degradation (Kaygun and Marzluff 2005b), as is the case
for NMD in yeast (Amrani et al. 2004). Histone mRNA
degradation requires Upf1, which interacts with SLBP at
the 3 end of histone mRNA after treatment with HU
(Kaygun and Marzluff 2005a). We postulate that the re-
cruitment of Upf1 results in the recruitment of the ap-
propriate TUTase and oligouridylation of histone
Figure 7. Model of histone mRNA degradation. A proposed model of histone mRNA degradation showing the transition of histone
mRNA from active translation as a circular mRNA, followed by the recruitment of Upf1 to the 3 end (Kaygun and Marzluff 2006)
when DNA replication is inhibited, followed by oligouridylation and degradation. SLBP is essential for translation (Sanchez and
Marzluff 2002), and SLIP1 bridges SLBP to the 5 end of histone mRNA (Cakmakci et al. 2007).
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mRNA. Lsm1–7 then binds to the oligo(U) tail (and may
be specifically recruited by the complex at the 3 end of
the mRNA). Recent studies by Kiledjian and coworkers
(Song and Kiledjian 2007) have shown that Lsm1–7 is the
major complex that binds to oligo(U) in HeLa cell ly-
sates, consistent with the proposed role of Lsm1–7 in
histone mRNA degradation.
Following oligouridylation it is likely that SLBP is still
bound to the histone mRNA, since SLBP and Lsm1 co-
immunoprecipitate from HU-treated cells (Fig. 1G), al-
though the association is sensitive to RNase, consistent
with the Lsm1 being bound to the oligo(U) tail rather
than to SLBP. Once Lsm1–7 is bound, then the decapping
complex can be recruited, and histone mRNA is de-
capped and degradation initiated from the 5 end. Alter-
natively the exosome may be recruited and the mRNA
degraded from the 3 end. Our data strongly suggest that
both of these events occur on most mRNAs, resulting in
simultaneous degradation of the same molecule 5 to 3
and 3 to 5. We cloned decay intermediates of single
molecules by cRT–PCR and obtained histone RNAs that
had both their 5 and 3 ends shortened, demonstrating
that individual molecules of histone mRNA are degraded
from both the 5 end and the 3 end (Fig. 4).
Initially 3-to-5 degradation may be relatively ineffi-
cient (possibly because of the presence of SLBP bound to
the stem–loop), and we detect intermediates in which
degradation has proceeded into the stem, and then the
RNA is oligouridylated at that site. These molecules
likely arise from stalling (and dissociation) of the exo-
some, requiring oligouridylation to reinitiate degrada-
tion 3 to 5.
Histone mRNA in the cytoplasm has been trimmed
Although the product of the in vitro processing reaction
of histone mRNAs ends in 5 nt, ACCCA, the 3 end of
cytoplasmic histone mRNA ends in 2–3 nt (usually AC
or ACC) after the stem–loop. Thus following processing
the 3 end must be trimmed. The properties of the
3hExo, which can remove 2–3 nt from the stem–loop
while SLBP is bound to the stem–loop (Dominski et al.
2003; Yang et al. 2006), suggests that the 3hExo carries
out this final reaction in histone mRNA maturation.
The oligo(U) stretches we detected were all added to the
trimmed histone mRNA.
Candidate TUTases for histone mRNA degradation
There are a group of genes initially thought to encode
poly(A) polymerases that were clearly distinct from the
canonical poly(A) polymerase that adds poly(A) tails to
mRNAs. These enzymes, such as Cid1 in Schizosaccha-
romyces pombe, were thought to be poly(A) polymerases
because they had some homology with the metazoan
Gld2 enzymes, which are responsible for cytoplasmic
polyadenylation of mRNA in metazoan oocytes (Kwak et
al. 2004; Stevenson and Norbury 2006). It is now clear
that at least some of these enzymes are also uridylyl
transferases. S. cerevisiae lacks any proteins that are
similar to Cid1 and has two family members, Trf4 and
Trf5, that are clearly nuclear, while many of the Cid1-
related proteins are cytoplasmic (Stevenson and Norbury
2006).
We identified seven human genes that encode putative
terminal uridylyl transferases (TUTases) based on their
homology with the U6-terminal transferase and the S.
pombe Cid1 enzyme, and the same enzymes were iden-
tified by Kwak and Wickens (2007). Knocking down two
of these enzymes, TUTase-1 and TUTase-3, but not the
other five (including TUTase-7, the Cid1 homolog), re-
sulted in a reduced rate of histone mRNA degradation
(Fig. 6). These two enzymes are cytoplasmic, and we pos-
tulate that one or both of them may be required for the
oligouridylation that initiates histone mRNA degrada-
tion. It is possible that one enzyme is responsible for the
initial terminal addition, and the other is required for the
addition to the partially degraded stem, which may be
necessary to effectively complete histone mRNA degra-
dation.
Benecke and coworkers (Trippe et al. 2006) recently
isolated the enzyme that adds oligo(U) tails to U6
snRNA, an essential reaction in the maturation of U6
snRNA. TUTase-1 has been previously implicated as the
mitochondrial poly(A) polymerase (Nagaike et al. 2005).
However, Norbury and coworkers (Rissland et al. 2007)
have shown that S. pombe Cid1 can add either uridine or
adenosine to RNA in vitro and that the specificity is
likely conferred by proteins associated with the TUTase,
since Cid1 complexes immunoprecipitated from cells
only add uridine in vitro. Thus it is possible that TUT-
ase-1 has multiple functions in the cell.
Is oligouridylation important for other mRNA
degradation pathways?
While addition of oligo(U) to a specific subset of mRNAs
to initiate RNA degradation has not been previously re-
ported in eukaryotic cells, there are examples of a poten-
tial role for oligouridylation in degradation of mRNAs
following siRNA cleavage, and of terminal addition of
nucleotides to prime degradation of RNAs in both the
eukaryotic nucleus and in prokaryotes. Shen and Good-
man (2004) reported that following miRNA cleavage of
mRNAs in plants, mouse, and Epstein-Barr virus, they
could detect oligouridylated mRNA fragments corre-
sponding to the 5 cleavage products. They suggested
that these were intermediates in the degradation of the
5 mRNA fragments produced by miRNA cleavage. In
the alga Chlamydomonas reinhardtii, Ibrahim et al.
(2006) suggested that the MUT68 protein, a poly(A) poly-
merase (CID12 ortholog in S. pombe), was responsible
for oligoadenylation of RISC-induced cleavage products
prior to cleavage. There is extensive evidence that deg-
radation of improperly processed tRNAs and rRNAs are
degraded in the nucleus by addition of oligo(A) by the
Trf4/Trf5 complex followed by recruitment of the exo-
some (LaCava et al. 2005; Vanacova et al. 2005).
Bacterial mRNA degradation is initiated by addition of
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oligo(A) to the 3 end of the mRNAs by a poly(A) poly-
merase that is homologous to Trf5. This oligo(A) tail can
then bind the Hfq protein (a homolog of the eukaryotic
Sm proteins) (Valentin-Hansen et al. 2004) and recruit
the degradosome, a bacterial homolog of the exosome
(Blum et al. 1999). In bacterial mRNA degradation, there
is addition of oligonucleotides to the 3 end of the RNA
whenever the degradosome pauses or is blocked by sec-
ondary structure of the mRNA. In bacteria, this addition
is catalyzed by polynucleotide phosphorylase, which
adds nucleotides nonspecifically (although As predomi-
nate since ATP is the most abundant nucleotide) (Mo-
hanty and Kushner 2000). It is thought that the single-
stranded tail then serves as a platform for the degrado-
some to reinitiate degradation of the mRNA, and that
cycles of nucleotide addition followed by exonucleolytic
degradation are characteristic of bacterial mRNA degra-
dation (Kushner 2004). Note that in addition to histone
mRNAs with oligo(U) tails, we also isolated mRNAs
that had oligo(U) tails added to mRNAs that had part of
the stem sequence removed. It is possible that these re-
sult from partial degradation of histone mRNA, followed
by stalling of the exosome, and then addition of oligo(U)
to the degradation intermediate, allowing completion of
mRNA degradation in a manner similar to that found in
degradation of bacterial mRNAs.
A striking finding is that individual histone mRNA
molecules are degraded both 5 to 3 and 3 to 5. A recent
report suggests that individual ARE-containing mRNAs
are also degraded from both ends (Murray and Schoen-
berg 2007), suggesting that this may be a common path-
way for mRNA degradation in mammalian cells. Al-
though we now know many of the requirements and the
likely pathway for histone mRNA degradation, we still
do not understand the molecular details of how the pro-
tein complex (including SLBP, Upf1, a uridylyl transfer-
ase, and Lsm1–7) is recruited to the 3 end of histone
mRNA to activate degradation, or the signals that acti-




HeLa cells were transfected with Lipofectamine 2000 (Invitro-
gen) using a two-hit RNAi method (Wagner and Garcia-Blanco
2002). Forty-eight hours following the second RNAi transfec-
tion, cells were treated with 5 mM HU for 0, 20, or 45 min.
Histone mRNA level was measured by Northern blotting or S1
nuclease assays. siRNAs were synthesized by Dharmacon, and
the targeted sequences for the genes are listed in Supplemental
Table 1.
Western blot analysis
Total cell lysates were prepared as described (Kaygun and Mar-
zluff 2005a). Detection of endogenous proteins was made pos-
sible by generous gifts of antibodies to Lsm1/CaSm, Dcp2, Xrn1,
Upf1, PM/Scl-100, Rrp41, and PTB. To determine the efficiency
of TUTase knockdowns, myc-tagged transgenes were cotrans-
fected with the second dose of siRNA. We assayed knockdown
48 h later using an anti-myc antibody (Upstate Biotechnology).
Northern blot and S1 nuclease protection assays
Total RNA was isolated using Trizol reagent (Invitrogen). For
Northern blot assays, 2 µg of total RNA were separated on 6%
acrylamide/7 M urea gels and transferred to Hybond N+ nitro-
cellulose membranes (Amersham). S1 nuclease protection as-
says to simultaneously measure the variant H3.3 and replica-
tion-dependent H2a mRNA were performed as described (Kay-
gun and Marzluff 2005a). Gels were dried and exposed to
PhosphorImager cassettes, quantified using ImageQuant, and
normalized to the amount of 7SK RNA.
cRT–PCR and cloning
cRT–PCR was performed similarly as described (Fromont-
Racine et al. 1993; Couttet et al. 1997). Briefly, total RNA (50
µg) was treated with 25 U of DNase (Promega) and 20 U of HPRI
(New England BioLabs) in a 100-µL reaction according to the
manufacturer’s protocols (Promega). The RNA was then ex-
tracted with phenol-chloroform and precipitated with ethanol.
For decapping, we incubated 10 µg of DNase-treated RNA, 2.5 U
of TAP (Epicentre Biotechnologies), and 20 U of HPRI in a 20-µL
reaction containing 1× TAP buffer (supplied by the manufac-
turer) for 1 h at 37°C and then raised the volume to 100 µL. The
RNA was recovered as above, washed in 80% ethanol, and re-
suspended in 10 µL of water. Circularization of 4 µg of total
decapped or nondecapped RNA was performed in a 400-µL re-
action containing 20 U of T4 RNA ligase (New England BioLabs)
and 20 U of HPRI (New England BioLabs) for 16 h at 16°C. The
samples were then extracted and precipitated as above and were
suspended in 12 µL of water.
Half of the ligation was subject to reverse transcription using
MMLV RT (Invitrogen) and a human histone H3 oligo, termed
primer 1 (5-CTTCTGGTAGCGCCGGATCTC-3), which was
designed to specifically target the ORF of the HIST2H3A and
HIST2H3C genes. The RT reaction was performed for 50 min at
37°C then heated for 15 min to 70°C. Subsequently, 2 µL were
used in 100-µL PCR reactions using Taq polymerase. Human
histone H3 primers 2 and 3 (5-GACTTGCGAGCAGTCTGCT
TAG-3 and 5-GCTGTTCGAAGACACGAACCTG-3, respec-
tively) were used to target regions in the ORF that amplify to-
ward the 5 and 3 UTRs. A total of 28–30 cycles were performed
under the conditions of 30 sec at 95°C, 30 sec at 52°C, and 30
sec at 72°C. Twenty microliters of the reaction were analyzed
on a 1.5%–3.0% agarose gel, and the identity of the PCR bands
was confirmed by sequencing TA-cloned (Invitrogen) products.
RT–PCR of oligouridylated histone mRNA
Synchronized HeLa cells were treated with 5 mM HU for 0, 15,
30, or 60 min. Four micrograms of total cell RNA (treated with
DNase) and a T7-oligo(A) primer (5-GTAATACGACTCACTA
TAGGGAAAAAAAA-3) were used to prime cDNA synthesis
in a RT reaction as above. The first round of PCR used a forward
histone primer targeting the 5 UTR of H2a/a, H3/2a/2c, or
H3/1d (5-GACTACTATCGCTGTCATGTCTG-3, 5-GGTAA
GCCCTGTGTTTTGGTTCGC-3, and 5-GAGACAGCATGG
CCCGTACTAAG-3, respectively) and a reverse T7 primer. We
performed 30 cycles on a 50-µL reaction containing a GC-rich
Pfu DNA polymerase (Invitrogen), 1× Buffer A supplied by the
manufacturer, and a similar cycling strategy as for the cRT–PCR
(30 sec at 95°C, 30 sec at 52°C, and 30 sec at 72°C). The second
round of PCR used 1 µL of product from the first round and
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identical cycling strategies (30 cycles) except that the reaction
contained 5% DMSO and used Taq DNA polymerase. The
primers in this reaction used primers to target sequences near
the C terminus of the respective histone ORFs (H2a/a, 5-GA
ACTGAACAAGCCTGCTGGGCAAAG-3 or 5-CCTGCAGC
TAGCGATCCG-3; H3/2a/2c and H3/2d used human histone
H3 primer 3 shown above). PCR products were separated on 2%
agarose gels, were visualized by ethidium bromide staining, and
were cloned and sequenced as described above.
Cell synchronization
HeLa cells were synchronized by DTB as described previously
(Whitfield et al. 2000).
RT–PCR of TUTase mRNA
TUTases were down-regulated by siRNA as described above.
Total RNA was isolated by Trizol reagent (Sigma), and 2 µg of
RNA were reverse transcribed with MMLV-RT (Invitrogen) and
random primers. RT reactions were subjected to PCR with the
oligos described in Supplemental Table 2.
Cloning of TUTases
TUTases were cloned by PCR from cDNA clones or by RT–PCR
from total HeLa RNA and cloned into pCDNA4-myc3 or
pCDNA3-Flag vectors. Accession numbers of the TUTases are
the following: TUTase-1 (BAB13981), TUTase-2 (BC04758),
TUTase-3 (Q8NDF8), TUTase-4 (XP_038288), TUTase-5
(AB005754), the U6 TUTase (BC110910), and TUTase-7
(BC032456).
Immunofluorescence and confocal microscopy
HeLa cells plated on coverslips were transiently transfected
with 0.5 or 1.5 µg of pCDNA4-myc3-Flag plasmids encoding the
ORF of TUTase-1 and TUTase-3 for 48 h. Cells were prepared
for immunofluorescence as described (Wagner and Marzluff
2006), and the N-terminal myc-epitope tag was detected with a
monoclonal mouse anti-myc antibody (Upstate Biotechnology).
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